Remove Blog Remove Chemotherapy Remove Compounding
article thumbnail

Manual IV Compounding – a Potential Recipe for Disaster?

Omnicell

When we talked about IV room compounding, I’ll never forget them telling me, “Making IVs is not like making pizzas at the local sub shop.” ” It’s not a big deal if you mix up sausage and pepperoni on a pizza, but one misstep in manual IV compounding could be absolutely devastating to a patient.

article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

The FDA Law Blog

whether growing or not; its seeds; resin extracted from any part; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin. chemotherapy-induced), pain, and post-traumatic stress disorder. chemotherapy-induced), and pain. chemotherapy-induced), and pain. 21 U.S.C. §

FDA 69
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HPAPIs – Current Interest of the Pharmaceutical Industry

Roots Analysis

Further, they are stable compounds and are retained ( in their active form ) within the body for longer durations, thereby decreasing the frequency of their administration. Hence, they are commonly used in the treatment of cancer, as part of the chemotherapy regime. They have the ability to prevent rapid growth and division of cells.

article thumbnail

Jiashu Xie, PhD

Blog: Ask a Student Pharmacist

Jiashu Xie, PhD eomizowh Wed, 06/21/2023 - 10:11 Expand all + Biography Research Summary Current research in the Pharmacokinetics (PK) lab has focused on profiling the in vitro ADME (absorption, distribution, metabolism, and excretion) and in vivo PK properties of lead compounds from medicinal chemistry efforts.

article thumbnail

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

The FDA Law Blog

We blogged on the December 5, 2023, letter from six Democratic governors to President Biden). The three letters together provide the range of actions DEA may take: no rescheduling from schedule I (former drug officials), rescheduling to schedule III (Democratic state attorneys general), or descheduling altogether (Democratic senators). (We